ASCO: Trial tests predictive value of blood test for EGFR

[NikoleV]

ASCO Video: Trial tests predictive value of blood test for EGFR inhibitor therapy

June 12th, 2013 - by Dr. Jack West

http://expertblog.lungevity.org/2013/06 ... r-therapy/

In this video podcast from our discussion at ASCO 2013, Dr. Nate Pennell from the Cleveland Clinic discusses the key findings from the PROSE trial, a study that looked at whether a blood-based test could help us anticipate which patients are more likely to benefit from an EGFR inhibitor like Tarceva (erlotinib) or chemotherapy as second line treatment for advanced NSCLC. Drs. Mary Pinder and I also join in with our thoughts about the potential implications of this work. (Click link above to view the video)

ASCO 2013 video Pennell on PROSE Study of Veristrat test in Advanced NSCLC

I hope it’s interesting and helpful.